EMBL-Cancer Core Europe Conference: Cancer Immunotherapy

2 - 4 February 2017, Heidelberg, Germany


Introduction
The European Molecular Biology Laboratory (EMBL) and Cancer Core Europe - a consortium of Europe's 6 leading Comprehensive Cancer Centers (Gustave Roussy Cancer Campus Grand Paris, France; Cambridge Cancer Centre, United Kingdom; Karolinska Institutet, Sweden; Netherlands Cancer Institute (NKI), Vall d’Hebron Institute of Oncology, Spain and the German Cancer Research Centre (DKFZ) with it's National Center for Tumour Diseases (NCT) Heidelberg) - are proud to join forces to host the  first EMBL-Cancer Core Europe Conference on Cancer Immunotherapy.

Topics

Unleashing endogenous immunity
Clinical studies of T cell-based immunotherapies
Markers of effective immune responses
Targeting the microenvironment
Inducing immunity
Speakers
  • TBC United Kingdom

Venue
EMBL ATC

EMBL ATC, Meyerhofstr. 1, Heidelberg, 69117 , Germany

Committee
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*